Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Age-Related Macular Degeneration at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Age-Related Macular Degeneration Session

Age-Related Macular Degeneration (AMD) stands as a prevalent cause of vision decline in individuals aged 50 and above. This condition specifically targets the macula, a crucial part of the retina essential for sharp, central vision. AMD manifests in two primary forms: dry AMD, characterized by a gradual deterioration of light-sensitive cells, and wet AMD, distinguished by abnormal blood vessel growth leading to swift vision impairment.

Various factors contribute to its development, including age, genetics, smoking, and dietary habits. Symptoms typically involve central vision distortion, color perception difficulties, and the appearance of wavy lines. While a cure remains elusive, treatments like anti-VEGF injections for wet AMD and lifestyle adjustments can help manage its progression. Consistent eye examinations play a pivotal role in early detection and effective management, highlighting the significance of proactive eye health practices as individuals age.

Topics Covered in Age-Related Macular Degeneration

Topic 01

Dry AMD & Geographic Atrophy

Topic 02

Neovascular AMD

Topic 03

Anti-VEGF Injections

Topic 04

Drusen & Early AMD

Topic 05

Genetic & Lifestyle Risk

Topic 06

AREDS Supplements

Featured Speakers — Age-Related Macular Degeneration 2027

Browse all speakers →

Recent Research Presented at Age-Related Macular Degeneration Sessions

Related Scientific Sessions at IOC 2027

Why Attend the Age-Related Macular Degeneration Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Age-Related Macular Degeneration work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Age-Related Macular Degeneration research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Age-Related Macular Degeneration track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Age-Related Macular Degeneration Conference 2027 — FAQs

What is the Age-Related Macular Degeneration track at IOC 2027?

The Age-Related Macular Degeneration track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Age-Related Macular Degeneration. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Age-Related Macular Degeneration sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Age-Related Macular Degeneration are all welcome — whether presenting or attending.

Can I present my research in the Age-Related Macular Degeneration track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Age-Related Macular Degeneration sessions?

Yes. IOC 2027 is a hybrid conference — attend the Age-Related Macular Degeneration track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us